Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Achieve Life Sciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −3 vs. Q3 2021
- Shares held
- 1.92M
- +136.6K (+7.7%) vs. Q3 2021
- Total value
- $14.9M
- −$220.0K (−1.5%) vs. Q3 2021
- New holders
- 4
- 9 more added
- Sold out
- 7
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Shay Capital LLC | 405,717 | $3.16M | 1.19% | +25,427+6.7% | Added |
| Vanguard Group Inc | 345,775 | $2.69M | 0.00% | +76,918+28.6% | Added |
| Perkins Capital Management Inc | 174,600 | $1.36M | 0.92% | +5,000+2.9% | Added |
| 683 Capital Management, LLC | 125,000 | $973.0K | 0.05% | 00.0% | Unchanged |
| Clearline Capital LP | 122,012 | $949.0K | 0.13% | 00.0% | Unchanged |
| Altium Capital Management LP | 122,000 | $949.0K | 0.27% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 100,302 | $780.0K | 0.00% | +74,965+295.9% | Added |
| Geode Capital Management, LLC | 85,554 | $665.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 68,950 | $536.0K | 0.00% | −3,050−4.2% | Reduced |
| Long Focus Capital Management, LLC | 60,000 | $467.0K | 0.13% | +60,000 | New |
| Morgan Stanley | 55,006 | $428.0K | 0.00% | −55,863−50.4% | Reduced |
| Royal Bank of Canada | 41,400 | $322.0K | 0.00% | +9,500+29.8% | Added |
| Franklin Resources Inc | 33,967 | $264.0K | 0.00% | −83−0.2% | Reduced |
| Oppenheimer & Co Inc | 24,800 | $193.0K | 0.00% | −200−0.8% | Reduced |
| Renaissance Technologies LLC | 23,800 | $185.0K | 0.00% | +1,200+5.3% | Added |
| Citadel Advisors LLC | 19,207 | $149.0K | 0.00% | +19,207 | New |
| Two Sigma Advisers, LP | 17,255 | $134.0K | 0.00% | −11,600−40.2% | Reduced |
| Northern Trust Corp | 17,014 | $132.0K | 0.00% | −298−1.7% | Reduced |
| Pura Vida Investments, LLC | 16,325 | $127.0K | 0.01% | +16,325 | New |
| BlackRock Inc. | 15,207 | $119.0K | 0.00% | +12,470+455.6% | Added |
| State Street Corp | 14,761 | $115.0K | 0.00% | 00.0% | Unchanged |
| Paradigm Financial Partners, LLC | 11,750 | $91.0K | 0.02% | −50−0.4% | Reduced |
| Occudo Quantitative Strategies LP | 11,001 | $86.0K | 0.01% | −1,967−15.2% | Reduced |
| Wells Fargo & Company | 5,593 | $43.0K | 0.00% | +1,003+21.9% | Added |
| Advisor Group Holdings, Inc. | 1,643 | $13.0K | 0.00% | +91+5.9% | Added |
| Newbridge Financial Services Group, Inc. | 308 | $2.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 341 | $2.00K | 0.00% | +341 | New |
| Tower Research Capital LLC (TRC) | 100 | $1.00K | 0.00% | −1,184−92.2% | Reduced |
| UBS Group AG | 80 | $1.00K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −38,491−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −18,532−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −10,962−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,039−100.0% | Sold out |
| Godsey & Gibb Associates | 0 | $0 | 0.00% | −453−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −46−100.0% | Sold out |